Unknown

Dataset Information

0

Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling.


ABSTRACT: Ligand-directed signaling has been suggested as a basis for the differences in responses evoked by otherwise receptor-selective agonists. The underlying mechanisms are not understood, yet clearer definition of this concept may be helpful in the development of novel, pathway-selective therapeutic agents. We previously showed that kappa-opioid receptor activation of JNK by one class of ligand, but not another, caused persistent receptor inactivation. In the current study, we found that the mu-opioid receptor (MOR) could be similarly inactivated by a specific ligand class including the prototypical opioid, morphine. Acute analgesic tolerance to morphine and related opioids (morphine-6-glucuronide and buprenorphine) was blocked by JNK inhibition, but not by G protein receptor kinase 3 knockout. In contrast, a second class of mu-opioids including fentanyl, methadone, and oxycodone produced acute analgesic tolerance that was blocked by G protein receptor kinase 3 knockout, but not by JNK inhibition. Acute MOR desensitization, demonstrated by reduced D-Ala(2)-Met(5)-Glyol-enkephalin-stimulated [(35)S]GTPgammaS binding to spinal cord membranes from morphine-pretreated mice, was also blocked by JNK inhibition; however, desensitization of D-Ala(2)-Met(5)-Glyol-enkephalin-stimulated [(35)S]GTPgammaS binding following fentanyl pretreatment was not blocked by JNK inhibition. JNK-mediated receptor inactivation of the kappa-opioid receptor was evident in both agonist-stimulated [(35)S]GTPgammaS binding and opioid analgesic assays; however, gene knockout of JNK 1 selectively blocked kappa-receptor inactivation, whereas deletion of JNK 2 selectively blocked MOR inactivation. These findings suggest that ligand-directed activation of JNK kinases may generally provides an alternate mode of G protein-coupled receptor regulation.

SUBMITTER: Melief EJ 

PROVIDER: S-EPMC2895055 | biostudies-literature | 2010 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling.

Melief Erica J EJ   Miyatake Mayumi M   Bruchas Michael R MR   Chavkin Charles C  

Proceedings of the National Academy of Sciences of the United States of America 20100603 25


Ligand-directed signaling has been suggested as a basis for the differences in responses evoked by otherwise receptor-selective agonists. The underlying mechanisms are not understood, yet clearer definition of this concept may be helpful in the development of novel, pathway-selective therapeutic agents. We previously showed that kappa-opioid receptor activation of JNK by one class of ligand, but not another, caused persistent receptor inactivation. In the current study, we found that the mu-opio  ...[more]

Similar Datasets

| S-EPMC3628274 | biostudies-literature
| S-EPMC3516711 | biostudies-literature
| S-EPMC8783671 | biostudies-literature
| S-EPMC3353249 | biostudies-literature
| S-EPMC5729556 | biostudies-literature
| S-EPMC85571 | biostudies-literature
| S-EPMC8896658 | biostudies-literature
| S-EPMC3534805 | biostudies-literature
| S-EPMC4357012 | biostudies-literature
| S-EPMC3319587 | biostudies-literature